Investing Profile

Thilo Schroeder

InvestorVC
Partner at Nextech Invest
nextechinvest.com/team/Zurich, Switzerland
Photo of Thilo Schroeder, Partner at Nextech Invest

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
$100K - $5.0M
$1.5M
19
CompanyStageDateRound SizeTotal Raised
Stipple Bio
Series AApr 2026$100M
$100M
Co-investors: Vineeta Agarwala (Andreessen Horowitz), Derek DiRocco (RA Capital)
Atavistik Bio
Series BMar 2026$40M
Series BDec 2025$120M
Series UnknownDec 2023$40M
Series AAug 2021$60M
$260M
Co-investors: Josh Wolfe (Lux Capital), John Josey (The Column Group), Tim Kutzkey (The Column Group)
Parabilis Medicines
Series FJan 2026$310M
Series EMar 2024$150M
$800M
Co-investors: Krishna Yeshwant (GV (Google Ventures)), Corey Goodman (venBio), Jake Simson (RA Capital)
Circle Pharma
Series DSep 2024$90M
Series CJun 2021$66M
Series BMar 2020$45M
$200M
Co-investors: Peter Svennilson (The Column Group), Eric Anschutz
Alterome Therapeutics
Series BApr 2024$130M
Series AJan 2022$64M
$230M
Co-investors: Arjun Goyal (Vida Ventures), Carl Gordon (OrbiMed Advisors)
Exo Therapeutics
Series BOct 2021$78M
$78M
Silverback Therapeutics
Series CSep 2020$85M
Series BMar 2020$79M
$160M
Co-investors: Jonathan Root (U.S. Venture Partners (USVP))
Revolution Medicines
Series CJul 2019$100M
Series BApr 2018$56M
$180M
Co-investors: Larry Lasky (The Column Group)